ArticleNutrients2018

Glycycoumarin Sensitizes Liver Cancer Cells to ABT-737 by Targeting De Novo Lipogenesis and TOPK-Survivin Axis.

Enxiang Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.